Medicines for Malaria Venture (MMV) (External organisation)

Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent

Description

Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
US9216983B2 - United States
Period22 Dec 2015
Held atMedicines for Malaria Venture (MMV), Switzerland
Degree of RecognitionNational

Documents & Links